Companies: 10,795·Total market cap: $144.5T
Algorae Pharmaceuticals Limited

Algorae Pharmaceuticals Limited

LVCLFOTCHealthcare● Active
$0.00
$-0.00(-58.33%)
Market Cap$5995284
P/E Ratio—
52W High$0.0084
52W Low$0.0018
Overview
股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Algorae Pharmaceuticals Limited（LVCLF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · LVCLF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.00lvclf eps ttm · lvclf earnings per shareEarnings history
PE Ratio (TTM)—lvclf pe ratio ttm · lvclf price to earningsPE Ratio deep dive
Revenue (TTM)125200.00lvclf revenue ttm · lvclf annual revenueFull revenue history
Dividend Yield不分红does lvclf pay dividends · lvclf dividend yieldDividend history
Shares Outstanding1.61Blvclf shares outstanding · lvclf floatShares outstanding history
Next EarningsTBAlvclf earnings date · lvclf next earningsEarnings history

探索 Algorae Pharmaceuticals Limited 数据

lvclf stock data · financials
市值$6.0Mlvclf market cap · lvclf valuation
分析师预测—
股息不分红does algorae pharmaceuticals limited pay dividends · lvclf dividend yield
营收—-100.00%algorae pharmaceuticals limited annual revenue · lvclf revenue
盈利EPS $-0.00+61.54%lvclf earnings · lvclf eps
市盈率—lvclf pe ratio · lvclf price to earnings

财务快照

完整财报
FY 2025Revenue$0.00▼ 100.00% YoY
202320242025
algorae pharmaceuticals limited revenue · lvclf revenue 2025
FY 2025Net Income-$802958.00▲ +61.68% YoY
202320242025
algorae pharmaceuticals limited net income · lvclf profit 2025
FY 2025EPS$-0.00▲ +61.54% YoY
202320242025
lvclf eps · algorae pharmaceuticals limited earnings per share 2025
TTM:Revenue: $125200.00Net Income: -$2.3MEPS: $-0.00View income statement →

股票表现

完整历史
1D-58.33%
1W-58.33%
1M-55.70%
3M-55.70%
YTD-55.70%
1Y-45.31%
5Y-66.35%

关于 Algorae Pharmaceuticals Limited

CEODavid Richard Hainsworth
IPO DateJun 1, 2010
Employees48
CountryAU
Websitealgoraepharma.com

Algorae Pharmaceuticals Limited established in 1987 and based in Melbourne, Australia, is a pharmaceutical development company. The firm primarily conducts its research and development in New Zealand…

BiotechnologyHealthcareOTCAU

what is algorae pharmaceuticals limited · lvclf stock overview · algorae pharmaceuticals limited company profile · who is algorae pharmaceuticals limited ceo · lvclf OTC · algorae pharmaceuticals limited headquarters · algorae pharmaceuticals limited business segments

关于股票概览与关键数据

Algorae Pharmaceuticals Limited（LVCLF）是 Biotechnology 行业的 Healthcare 类公司，于 Jun 1, 2010 在 OTC 上市。截至最近交易日，LVCLF 股价为 $0.00，市值约为 $6.0M。过去12个月累计回报 -45.31%，年初至今回报 -55.70%。

2025 财年 Algorae Pharmaceuticals Limited 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Algorae Pharmaceuticals Limited（LVCLF）股价为 $0.00，在 OTC 上市，52周区间为 $0.00 – $0.01。

LVCLF 最新股价LVCLF quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议